Please provide your email address to receive an email when new articles are posted on . A novel adhesive-based wearable cardioverter defibrillator exceeded its safety and efficacy performance goals.

A novel, water-resistant patch-wearable cardioverter-defibrillator is safe and effective for patients at risk for sudden cardiac arrest. HealthDay News — A novel, water-resistant patch-wearable ...

Kestra Medical Technologies (Nasdaq:KMTS) announced that it priced an upsized underwritten offering worth approximately $138 ...

KIRKLAND, Wash.--(BUSINESS WIRE)--Kestra Medical Technologies announced today that the ASSURE ® Wearable Cardioverter Defibrillator (WCD) system is now available in-network to over 100 million ...

KIRKLAND, Wash.--(BUSINESS WIRE)--Kestra ™ Medical Technologies, Inc. announced today that the company has received U.S. Food and Drug Administration (FDA) Premarket Approval for the ASSURE ® Wearable ...

KIRKLAND, Wash., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced its participation in the ...

The U.S. Food and Drug Administration today approved a new indication for the LifeVest wearable cardioverter defibrillator. The LifeVest is approved for certain children who are at risk for sudden ...

Research and Markets has announced the addition of the "Global Wearable Cardioverter Defibrillator Market Analysis 2016 - Forecast to 2022" report to their offering. The report contains up to date ...